Curaleaf Holdings Files 6-K, Includes Press Release

Ticker: CURLF · Form: 6-K · Filed: 2024-04-05T00:00:00.000Z

Sentiment: neutral

Topics: reporting, filing, press-release

TL;DR

Curaleaf filed a 6-K with a press release attached. Check 99.1 for news.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on April 5, 2024, reporting for the month of April 2024. The filing indicates that Curaleaf will file its annual reports under Form 40-F. The report includes a press release as Exhibit 99.1. Peter Clateman, Chief Legal Officer, signed the report on April 4, 2024.

Why It Matters

This filing provides an update on Curaleaf's reporting status and includes a press release, which may contain material information for investors.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that primarily serves as an update and includes a press release, with no immediate financial or operational disclosures that suggest high risk.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, filed for the month of April 2024, and includes Exhibit 99.1, a Press Release.

Which form will Curaleaf Holdings, Inc. use for its annual reports?

Curaleaf Holdings, Inc. will file its annual reports under cover of Form 40-F.

Who signed this Form 6-K filing on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the Form 6-K on behalf of Curaleaf Holdings, Inc.

On what date was this Form 6-K filed?

This Form 6-K was filed on April 5, 2024.

What is included as an exhibit in this filing?

Exhibit 99.1, a Press Release, is included in this filing.

From the Filing

0001756770-24-000022.txt : 20240405 0001756770-24-000022.hdr.sgml : 20240405 20240404183524 ACCESSION NUMBER: 0001756770-24-000022 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240404 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 24824322 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover040424.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: April 4, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated April 4 , 2024 EX-99.1 2 pressrelease040424.htm EX-99.1 Document Curaleaf to Report First Quarter 2024 Financial and Operational Results NEW YORK, April 4, 2024 -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company") , a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2024 after market close on May 9, 2024. Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights. Event: Curaleaf First Quarter 2024 Financial Earnings Conference Call Date: Thursday, May 9, 2024 Time: 5:00 p.m. ET Live Call: +1-844-512-2926 (U.S.), +1-416-639-5883 (Canada) or +1-412-317-6300 (International) Passcode: 7489402 Webcast: https://ir.curaleaf.com/events For interested individuals unable to join the conference call, a dial-in replay of the call will be available until May 16, 2024, and can be accessed by dialing +1-877-344-7529 (U.S.), +1-855-669-9658 (Canada) or +1-412-317-0088 (International) and entering replay pin number: 7935470 About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distr

View on Read The Filing